22.03MMarket Cap-920P/E (TTM)
1.3800High1.3200Low27.93KVolume1.3200Open1.3000Pre Close37.42KTurnover0.20%Turnover RatioLossP/E (Static)15.97MShares1.690052wk High1.85P/B19.17MFloat Cap0.470052wk Low--Dividend TTM13.89MShs Float10.8700Historical High--Div YieldTTM4.62%Amplitude0.4700Historical Low1.3390Avg Price1Lot Size
Context Therapeutics Stock Forum
Update
PHILADELPHIA, April 01, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. ("Context" or the "Company") (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that on March 28, 2024, the Company submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration to begin a first-in-human clinical study of CTIM-76. ...
what a great day trading - winning made simple
$Context Therapeutics(CNTX.US)$
$cbdMD(YCBD.US)$
$China SXT Pharmaceuticals(SXTC.US)$
$China Green Agriculture(CGA.US)$
multiple winners 🏆💪🏻
Apextradez 🔗 up with me 🤩 supporters get free access to mega elite alerts 🫵🏻 can win if you want to get serious in 2024 and winning is your goal
$Dcth massive fda approval
Move in on panic
will it continue to rise?
@Matthew D
have u sell?
Will you 🚀🚀🚀🚀🚀🚀🚀🚀
No comment yet